C07D 263/02
Not condensed with other rings
Official title: not condensed with other rings
C07D263/02 (Not condensed with other rings) appears on 4,074 US grants and 3,070 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,074
- Published applications
- 3,070
- Assignees
- 1,464
- Inventors
- 10,513
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 60 | 0 |
| 1977 | 87 | 0 |
| 1978 | 162 | 0 |
| 1979 | 70 | 0 |
| 1980 | 77 | 0 |
| 1981 | 82 | 0 |
| 1982 | 62 | 0 |
| 1983 | 50 | 0 |
| 1984 | 51 | 0 |
| 1985 | 45 | 0 |
| 1986 | 25 | 0 |
| 1987 | 41 | 0 |
| 1988 | 33 | 0 |
| 1989 | 54 | 0 |
| 1990 | 49 | 0 |
| 1991 | 52 | 0 |
| 1992 | 63 | 0 |
| 1993 | 89 | 0 |
| 1994 | 65 | 0 |
| 1995 | 73 | 0 |
| 1996 | 79 | 0 |
| 1997 | 110 | 0 |
| 1998 | 87 | 0 |
| 1999 | 106 | 0 |
| 2000 | 84 | 0 |
| 2001 | 112 | 21 |
| 2002 | 138 | 126 |
| 2003 | 130 | 149 |
| 2004 | 93 | 190 |
| 2005 | 78 | 186 |
| 2006 | 97 | 141 |
| 2007 | 91 | 149 |
| 2008 | 86 | 142 |
| 2009 | 74 | 156 |
| 2010 | 111 | 171 |
| 2011 | 90 | 138 |
| 2012 | 102 | 122 |
| 2013 | 108 | 126 |
| 2014 | 133 | 141 |
| 2015 | 112 | 119 |
| 2016 | 108 | 115 |
| 2017 | 101 | 102 |
| 2018 | 76 | 93 |
| 2019 | 80 | 106 |
| 2020 | 76 | 100 |
| 2021 | 63 | 100 |
| 2022 | 63 | 81 |
| 2023 | 59 | 116 |
| 2024 | 57 | 83 |
| 2025 | 49 | 58 |
| 2026 | 31 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Industrial synthesis of serinol6 Oct 2026US 12,753,146 B2Bracco Imaging S.P.A.
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Method for producing amide group-containing compound using n-carboxyamino acid anhydride24 Sep 2026US 2026/0285804 A1Chugai Seiyaku Kabushiki Kaisha
- Process for purifying 2-phenyl-4-(3-carboalkoxypropionyl)-1,3-oxazolin-5-one and new crystalline form b of 2-phenyl-4-(3-carbomethoxypropionyl)-1,3-oxazolin-5-one24 Sep 2026US 2026/0285820 A1Heraeus Precious Metals GmbH & Co. KG
- Substituted oxazolidinones and imidazolinones as herbicides24 Sep 2026US 2026/0285850 A1FMC Corporation
Most cited
By later US patents
- Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof1,998US 5,143,854 AAffymax Technologies N.V. · 1992
- Array of oligonucleotides on a solid substrate1,585US 5,445,934 AAffymax Technologies N.V. · 1995
- Arrays of materials attached to a substrate1,410US 5,744,305 AAffymetrix, Inc. · 1998
- Very large scale immobilized polymer synthesis967US 5,424,186 AAffymax Technologies N.V. · 1995
- Method of detecting nucleic acids962US 5,800,992 A1998